Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy. [electronic resource]
Producer: 20160712Description: 438-44 p. digitalISSN:- 1476-5500
- Adenocarcinoma -- secondary
- Animals
- Antineoplastic Agents -- therapeutic use
- Aurora Kinase B -- antagonists & inhibitors
- Azepines -- pharmacology
- Bacterial Proteins -- genetics
- Breast Neoplasms -- pathology
- Chlorocebus aethiops
- Combined Modality Therapy
- Female
- Gene Expression Regulation
- Humans
- Immunoglobulin lambda-Chains -- genetics
- Interleukins -- biosynthesis
- Lung Neoplasms -- secondary
- Measles virus
- Mice
- Mice, Nude
- Oncolytic Virotherapy
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- pharmacology
- Transgenes
- Vero Cells
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.